Search research articles
Contact Us
Filters
Showing results (71-80 of 80) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 80 results.
Bone Marrow Transplantation
|
May 1, 1996
The treatment of chronic myelogenous leukemia by interferon and cytosine-arabinoside: rational and design of the French trials. French CML Study Group
F Guilhot, A Guerci, D Fiere, et al.
Leukemia
|
June 24, 2000
Treatment of relapsing acute promyelocytic leukemia by all-trans retinoic acid therapy followed by timed sequential chemotherapy and stem cell transplantation. APL Study Group. Acute promyelocytic leukemia
X Thomas, H Dombret, C Cordonnier, et al.
Advances in Experimental Medicine and Biology
|
September 29, 1999
Quinine improves results of intensive chemotherapy (IC) in myelodysplastic syndromes (MDS) expressing P-glycoprotein (PGP). Updated results of a randomized study. Groupe Français des Myélodysplasies (GFM) and Groupe GOELAMS
E Wattel, E Solary, B Hecquet, et al.
British Journal of Haematology
|
November 7, 2024
Clinical outcomes in patients in any phase of CML treated with ponatinib in France-Data from the TOPASE observational study
F Huguet, A Guerci-Bresler, G Roth-Guepin, et al.
British Journal of Haematology
|
September 12, 1998
Quinine improves the results of intensive chemotherapy in myelodysplastic syndromes expressing P glycoprotein: results of a randomized study
E Wattel, E Solary, B Hecquet, et al.
The American Journal of Cardiology
|
April 24, 1999
Prior aspirin use predicts worse outcomes in patients with non-ST-elevation acute coronary syndromes. PURSUIT Investigators. Platelet IIb/IIIa in Unstable angina: Receptor Suppression Using Integrilin Therapy
J H Alexander, R A Harrington, R H Tuttle, et al.
Leukemia
|
April 18, 2002
Results of a phase II trial of a combination of oral cytarabine ocfosfate (YNK01) and interferon alpha-2b for the treatment of chronic myelogenous leukemia patients in chronic phase
F Maloisel, A Guerci, D Guyotat, et al.
Annals of Hematology
|
January 30, 2013
High response rate and improved exercise capacity and quality of life with a new regimen of darbepoetin alfa with or without filgrastim in lower-risk myelodysplastic syndromes: a phase II study by the GFM
C Kelaidi, O Beyne-Rauzy, T Braun, et al.
British Journal of Haematology
|
December 21, 2000
Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis: results of APL 93 trial
S De Botton, S Chevret, M Sanz, et al.
Leukemia
|
October 27, 2015
Lenalidomide with or without erythropoietin in transfusion-dependent erythropoiesis-stimulating agent-refractory lower-risk MDS without 5q deletion
A Toma, O Kosmider, S Chevret, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 80) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 80 results.
Bone Marrow Transplantation
|
May 1, 1996
The treatment of chronic myelogenous leukemia by interferon and cytosine-arabinoside: rational and design of the French trials. French CML Study Group
F Guilhot, A Guerci, D Fiere, et al.
Leukemia
|
June 24, 2000
Treatment of relapsing acute promyelocytic leukemia by all-trans retinoic acid therapy followed by timed sequential chemotherapy and stem cell transplantation. APL Study Group. Acute promyelocytic leukemia
X Thomas, H Dombret, C Cordonnier, et al.
Advances in Experimental Medicine and Biology
|
September 29, 1999
Quinine improves results of intensive chemotherapy (IC) in myelodysplastic syndromes (MDS) expressing P-glycoprotein (PGP). Updated results of a randomized study. Groupe Français des Myélodysplasies (GFM) and Groupe GOELAMS
E Wattel, E Solary, B Hecquet, et al.
British Journal of Haematology
|
November 7, 2024
Clinical outcomes in patients in any phase of CML treated with ponatinib in France-Data from the TOPASE observational study
F Huguet, A Guerci-Bresler, G Roth-Guepin, et al.
British Journal of Haematology
|
September 12, 1998
Quinine improves the results of intensive chemotherapy in myelodysplastic syndromes expressing P glycoprotein: results of a randomized study
E Wattel, E Solary, B Hecquet, et al.
The American Journal of Cardiology
|
April 24, 1999
Prior aspirin use predicts worse outcomes in patients with non-ST-elevation acute coronary syndromes. PURSUIT Investigators. Platelet IIb/IIIa in Unstable angina: Receptor Suppression Using Integrilin Therapy
J H Alexander, R A Harrington, R H Tuttle, et al.
Leukemia
|
April 18, 2002
Results of a phase II trial of a combination of oral cytarabine ocfosfate (YNK01) and interferon alpha-2b for the treatment of chronic myelogenous leukemia patients in chronic phase
F Maloisel, A Guerci, D Guyotat, et al.
Annals of Hematology
|
January 30, 2013
High response rate and improved exercise capacity and quality of life with a new regimen of darbepoetin alfa with or without filgrastim in lower-risk myelodysplastic syndromes: a phase II study by the GFM
C Kelaidi, O Beyne-Rauzy, T Braun, et al.
British Journal of Haematology
|
December 21, 2000
Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis: results of APL 93 trial
S De Botton, S Chevret, M Sanz, et al.
Leukemia
|
October 27, 2015
Lenalidomide with or without erythropoietin in transfusion-dependent erythropoiesis-stimulating agent-refractory lower-risk MDS without 5q deletion
A Toma, O Kosmider, S Chevret, et al.
Page
of 8